
==== Front
Bone Marrow Transplant
Bone Marrow Transplant
Bone Marrow Transplantation
0268-3369
1476-5365
Nature Publishing Group UK London

38907026
2336
10.1038/s41409-024-02336-w
Correction
Correction: Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
http://orcid.org/0000-0002-1238-6970
Sureda Anna asureda@iconcologia.net

1
Carpenter Paul A. 2
Bacigalupo Andrea 3
http://orcid.org/0000-0003-2513-0533
Bhatt Vijaya Raj 4
http://orcid.org/0000-0002-0974-1249
de la Fuente Josu 56
Ho Aloysius 7
http://orcid.org/0000-0003-0475-3926
Kean Leslie 89
http://orcid.org/0000-0003-2949-4166
Lee Jong Wook 10
http://orcid.org/0009-0005-5519-9154
Sánchez-Ortega Isabel 11
http://orcid.org/0000-0002-3304-9965
Savani Bipin N. 12
http://orcid.org/0000-0002-2780-2981
Schetelig Johannes 13
Stadtmauer Edward A. 14
Takahashi Yoshiyuki 15
http://orcid.org/0000-0003-4404-2870
Atsuta Yoshiko 1617
Koreth John 18
http://orcid.org/0000-0001-5103-9966
Kröger Nicolaus 19
http://orcid.org/0000-0002-8281-3245
Ljungman Per 20
Okamoto Shinichiro 21
http://orcid.org/0000-0002-7592-2224
Popat Uday 22
http://orcid.org/0000-0002-5810-1192
Soiffer Robert 18
Stefanski Heather E. 23
http://orcid.org/0000-0001-7394-5185
Kharfan-Dabaja Mohamed A. 24
1 https://ror.org/021018s57 grid.5841.8 0000 0004 1937 0247 Clinical Hematology Department, Institut Català d’Oncologia-L’Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain
2 https://ror.org/007ps6h72 grid.270240.3 0000 0001 2180 1622 Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA USA
3 grid.411075.6 0000 0004 1760 4193 Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
4 grid.266813.8 0000 0001 0666 4105 Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE USA
5 grid.426467.5 0000 0001 2108 8951 Department of Paediatrics, Imperial College Healthcare NHS Trust, St Mary’s Hospital, London, UK
6 https://ror.org/041kmwe10 grid.7445.2 0000 0001 2113 8111 Department of Immunology & Inflammation, Imperial College London, London, UK
7 https://ror.org/03bqk3e80 grid.410724.4 0000 0004 0620 9745 Department of Haematology, Singapore General Hospital and National Cancer Centre Singapore, Singapore, Singapore
8 https://ror.org/00dvg7y05 grid.2515.3 0000 0004 0378 8438 Stem Cell Transplantation Program. Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA USA
9 https://ror.org/02jzgtq86 grid.65499.37 0000 0001 2106 9910 Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA USA
10 grid.411947.e 0000 0004 0470 4224 Division of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Republic of Korea
11 EBMT Medical officer, EBMT executive office, Barcelona, Spain
12 https://ror.org/05dq2gs74 grid.412807.8 0000 0004 1936 9916 Division of Hematology/ Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN USA
13 https://ror.org/04za5zm41 grid.412282.f 0000 0001 1091 2917 Medical Department I, University Hospital Carl Gustav Carus. TU Dresden & DKMS Group, Clinical Trials Unit, Dresden, Germany
14 grid.25879.31 0000 0004 1936 8972 Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
15 grid.27476.30 0000 0001 0943 978X Department of Pediatrics, Nagoya University Graduate School of Medicine, Aichi, Japan
16 https://ror.org/04e8cy037 grid.511247.4 Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
17 https://ror.org/02h6cs343 grid.411234.1 0000 0001 0727 1557 Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan
18 https://ror.org/02jzgtq86 grid.65499.37 0000 0001 2106 9910 Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA USA
19 https://ror.org/01zgy1s35 grid.13648.38 0000 0001 2180 3484 Department for Stem Cell Transplantation, University Medical Center Hamburg, Hamburg, Germany
20 grid.24381.3c 0000 0000 9241 5705 Department. of Cellular Therapy and Allogeneic Stem Cell Transplantation. Karolinska Comprehensive Cancer Center, Karolinska University Hospital Huddinge, Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
21 https://ror.org/02kn6nx58 grid.26091.3c 0000 0004 1936 9959 Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
22 https://ror.org/04twxam07 grid.240145.6 0000 0001 2291 4776 Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX USA
23 grid.422289.7 0000 0004 0628 2731 Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, MN USA
24 https://ror.org/02qp3tb03 grid.66875.3a 0000 0004 0459 167X Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, FL USA
21 6 2024
21 6 2024
2024
59 9 13351335
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Subject terms

Health care
Diseases
issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcCorrection to: Bone Marrow Transplantation 10.1038/s41409-024-02251-0, published online 5 March 2024

The Funding information section was missing from this article and should have read:

CIBMTR is supported primarily by the Public Health Service U24CA076518 from the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases (NIAID); 75R60222C00011 from the Health Resources and Services Administration (HRSA); and N00014-23-1-2057 and N00014-24-1-2057 from the Office of Naval Research. Support is also provided by the Medical College of Wisconsin, NMDP, Gateway for Cancer Research, Pediatric Transplantation and Cellular Therapy Consortium and from the following commercial entities: AbbVie; Actinium Pharmaceuticals, Inc.; Adaptive Biotechnologies Corporation; ADC Therapeutics; Adienne SA; Alexion; Allogene; AlloVir, Inc.; Amgen, Inc.; Astellas Pharma US; AstraZeneca; Atara Biotherapeutics; BeiGene; BioLineRX; Blue Spark Technologies; bluebird bio, inc.; Blueprint Medicines; Bristol Myers Squibb Co.; CareDx Inc.; CSL Behring; CytoSen Therapeutics, Inc.; DKMS; Eurofins Viracor, DBA Eurofins Transplant Diagnostics; Gamida-Cell, Ltd.; Gift of Life Biologics; Gift of Life Marrow Registry; GlaxoSmithKline; HistoGenetics; Incyte Corporation; Iovance; Janssen Research & Development, LLC; Janssen/Johnson & Johnson; Jasper Therapeutics; Jazz Pharmaceuticals, Inc.; Karius; Kashi Clinical Laboratories; Kiadis Pharma; Kite, a Gilead Company; Kyowa Kirin; Labcorp; Legend Biotech; Mallinckrodt Pharmaceuticals; Med Learning Group; Merck & Co.; Mesoblast; Millennium, the Takeda Oncology Co.; Miller Pharmacal Group, Inc.; Miltenyi Biotec, Inc.; MorphoSys; MSA-EDITLife; Neovii Pharmaceuticals AG; Novartis Pharmaceuticals Corporation; Omeros Corporation; OptumHealth; Orca Biosystems, Inc.; OriGen BioMedical; Ossium Health, Inc.; Pfizer, Inc.; Pharmacyclics, LLC, An AbbVie Company; PPD Development, LP; REGiMMUNE; Registry Partners; Rigel Pharmaceuticals; Sanofi; Sarah Cannon; Seagen Inc.; Sobi, Inc.; Stemcell Technologies; Stemline Technologies; STEMSOFT; Takeda Pharmaceuticals; Talaris Therapeutics; Vertex Pharmaceuticals; Vor Biopharma Inc.; WellSky; Xenikos BV.

The original article has been corrected.
